We focus on economically important respiratory and enteric diseases, adding value to our customers and enhancing profitability.
We are a publicly listed profitable animal health company providing quality veterinary products to improve livestock productivity and welfare.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
*Aivlosin® is sold in some markets under the tradename Valosin®.
ECO Animal Health is also investing in the next generation of animal health products through a self-funded R&D pipeline. ECOVAXXIN® MS, a poultry vaccine targeting Mycoplasma synoviae infection, is the first product from our pipeline to have commercially launched in the European Union.
We are proud to play an important part in the supply of healthy, nutritious and safe food.
We operate through a network of partnerships in key markets around the globe.
ECO Animal Health is a member of the National Office of Animal Health (NOAH) and supports the Responsible Use of Medicines in Agriculture Alliance (RUMA).
The ECO Research and Development function is aligned with our mission and vision, focused on delivering innovative animal health products for disease prevention and treatment to optimise livestock wellbeing and productivity.
Headquartered in the UK, we are a world leader in animal health focused on achieving long-term sustainable results.
